BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4934592)

  • 21. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers].
    Rautlin de la Roy Y DE; Beauchant G; Brisou J; Dussouil P; Charpentier
    Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1054-9. PubMed ID: 4317484
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoxyl: a review of the results of its use over a five-year period in the tuberculosis field service of a large urban area.
    Gallen CS
    Antibiot Chemother; 1970; 16():139-48. PubMed ID: 5535610
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
    Trnka L; Tousek J
    Chemotherapy; 1974; 20(3):165-76. PubMed ID: 4136827
    [No Abstract]   [Full Text] [Related]  

  • 26. [The secondary sensitivity of mycobacteria].
    Hejný J; Hejná A
    Z Tuberk Erkr Thoraxorg; 1967; 126(5):303-5. PubMed ID: 4299812
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tuberculostatic tolerance of a tuberculous kidney].
    Strauss I
    Z Urol Nephrol; 1969; 62(9):651-6. PubMed ID: 4325816
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination treatment with capreomycin of pretreated cavernous pulmonary tuberculosis.
    Kittel H
    Antibiot Chemother; 1970; 16():36-42. PubMed ID: 4108894
    [No Abstract]   [Full Text] [Related]  

  • 30. [Initial provisional record of a controlled trial of isoniazid-rifomycin-thiocarlide versus isoniazid-streptomycin-thiocarlide in active pulmonary tuberculosis not yet treated].
    Willa C; Favez G
    Acta Tuberc Pneumol Belg; 1969; 60(3):577-82. PubMed ID: 4906106
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriology of tuberculosis with special reference to kanamycin and related drugs.
    Dye WE
    Ann N Y Acad Sci; 1966 Jun; 132(2):901-4. PubMed ID: 4290030
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
    [No Abstract]   [Full Text] [Related]  

  • 33. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental therapy with so-called "minor" tuberculostatics].
    Freerksen E
    Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of results of chemotherapy in tuberculosis with special consideration of ethambutol.
    Heise A; Blaha H; Reimann B
    Antibiot Chemother; 1970; 16():294-7. PubMed ID: 4332037
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 37. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thiocarlide. Attempt of an evaluation].
    Protivinsky R
    Ther Ggw; 1969 Oct; 108(10):1410-1 passim. PubMed ID: 4908478
    [No Abstract]   [Full Text] [Related]  

  • 39. Ethambutol in the retreatment of chronic pulmonary tuberculosis.
    Lees AW; Tyrrell WF; Smith J; Allan GW
    Br J Dis Chest; 1970 Apr; 64(2):85-9. PubMed ID: 5432629
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of urogenital tuberculosis. Urological aspects].
    Tümmers H; Brühl P
    Fortschr Med; 1974 Jan; 92(3):101-7. PubMed ID: 4131872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.